共 50 条
- [31] Outcomes in patients with ST-elevation myocardial infarction treated with sirolimus-eluting stents (SES) versus paclitaxel-eluting stents (PES): Results from the STENT group AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 78M - 78M
- [36] A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial EUROINTERVENTION, 2018, 14 (06) : 692 - 699
- [37] Comparison of eighteen-month clinical outcomes of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B66 - B67
- [38] Comparison of 24-Month Clinical Outcomes of Endothelial Progenitor Cell Capture Stent versus Sirolimus-Eluting Bioabsorbable Polymer-Coated Stent versus Bare Metal Stents In Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 131I - 131I
- [39] 5-Year Follow-Up After Primary Percutaneous Coronary Intervention With a Paclitaxel-Eluting Stent Versus a Bare-Metal Stent in Acute ST-Segment Elevation Myocardial Infarction A Follow-Up Study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction With ST-Segment Elevation) Trial JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (01) : 24 - 29
- [40] Two-by-two factorial comparison of high-bolus-close tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: Design and rationale for the MULTI-STRATEGY trial AMERICAN HEART JOURNAL, 2007, 154 (01) : 39 - 45